Pfizer Reports Fourth-Quarter And Full-Year 2012 Results; Provides 2013 Financial Guidance

Pfizer Inc. (NYSE: PFE):
($ in millions, except per share amounts)              
 
Fourth-Quarter Full-Year
  2012        

2011 (5)
Change   2012    

2011 (5)
Change
Reported Revenues $ 15,068 $ 16,141 (7 %) $ 58,986 $ 65,259 (10 %)
Adjusted Income (2) 3,512 3,784 (7 %) 16,476 17,839 (8 %)
Adjusted Diluted EPS (2) 0.47 0.49 (4 %) 2.19 2.27 (4 %)
Reported Net Income (3) 6,315 1,439 * 14,570 10,009 46 %
Reported Diluted EPS (3) 0.85 0.19 * 1.94 1.27 53 %

See end of text prior to tables for notes.

If you liked this article you might like

The 6 Medications Being Used to Tackle the Opioid Epidemic

Dow, S&P 500 Set New Records as Fed Moves to Unwind Balance Sheet

Stocks In Negative Territory as Chances for December Hike Surge

The Wait for 'Milestone' Fed Meeting Keeps Stocks in Flux